Adar1 Capital Management, LLC Day One Biopharmaceuticals, Inc. Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 35,100 shares of DAWN stock, worth $507,897. This represents 0.09% of its overall portfolio holdings.
Number of Shares
35,100Holding current value
$507,897% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
166Shares Held
71.9MCall Options Held
163KPut Options Held
183K-
Ra Capital Management, L.P. Boston, MA7.87MShares$114 Million1.63% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$93 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$66.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$65.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$54.7 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.06B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...